我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
77
9 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1906
进行中(未招募)
1
1.3%
已完成
50
64.9%
尚未招募
8
10.4%
招募中
11
14.3%
终止
Unknown
6
7.8%
暂无批准数据
- Researchers at Dongguk University developed an electromagnetic field (EMF)-inducible gene switch enabling fully reversible, safe, and precise remote control of gene expression. - The switch uses the Lgr4 gene promoter and was validated in transgenic mice, showing tunable, localized expression that returns to baseline within 24 hours after stimulation stops. - A genome-wide CRISPR-Cas9 screen identified cytochrome b5 type B (Cyb5b) as the first reported molecular sensor for electromagnetic fields. - The platform demonstrated applications in Alzheimer's disease modeling, reversing aging markers, and restoring serotonin levels to reduce depression-like behaviors in mice.